Skip to content

DataMeds AI, Inc.

MEDS · XNAS

CIK 2030763fmd_1R143T4N52T00AQW7N40FZPNSAWholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard

Coverage: Jan 01, 2023 to Jun 30, 2026, 11 periods

Income Statement · Annual · Millions · USD
Line itemFY2023FY2024FY2025
Total revenues–1823
Cost of revenue–1630
Gross profit–2(6)
Selling, general and administrative––72
Total operating expenses3887
Compensation and benefits––0
Operating income(3)(6)(94)
Interest expense015
Other non-operating income (expense)(0)(1)(8)
Income before taxes(3)(7)(101)
Net income(3)(7)(101)
DataMeds AI, Inc. (MEDS) financial statements · FinancialMD